Integrated Safety Assessment of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers-Reference-Cited by-同舟云学术

Integrated Safety Assessment of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers

Published:2016-10 Issue:10 Volume:24 Page:1771-1782
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Crooke Stanley T,Baker Brenda F,Kwoh T Jesse,Cheng Wei,Schulz Dan J,Xia Shuting,Salgado Nelson,Bui Huynh-Hoa,Hart Christopher E,Burel Sebastien A,Younis Husam S,Geary Richard S,Henry Scott P,Bhanot Sanjay

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference52 articles.

1. Gene-targeting pharmaceuticals for single-gene disorders;Beaudet;Hum Mol Genet,2016

2. An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies;McClorey;Curr Opin Pharmacol,2015

3. Antisense technology: an emerging platform for cardiovascular disease therapeutics;Lee;J Cardiovasc Transl Res,2013

4. Antisense-based therapy for the treatment of spinal muscular atrophy;Rigo;J Cell Biol,2012

5. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform;Bennett;Annu Rev Pharmacol Toxicol,2010

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for ultrarare diseases: a geneticist’s perspective;Journal of Biomedical Science;2024-08-13

2. Genotypic and phenotypic analysis of 173 patients with extremely rare pathogenic mutations who applied for experimental antisense oligonucleotide treatment;2024-08-06

3. Unveiling the potential of antisense oligonucleotides: Mechanisms, therapies, and safety insights;Drug Development Research;2024-05-19

4. Safety and Tolerability of GalNAc₃-Conjugated Antisense Drugs Compared to the Same-Sequence 2′-O-Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial Data;Nucleic Acid Therapeutics;2024-02-01

5. Peptide Conjugates of a 2′-O-Methoxyethyl Phosphorothioate Splice-Switching Oligonucleotide Show Increased Entrapment in Endosomes;ACS Omega;2023-10-17